Select Noncontrolling Interest In Consolidated Entity from 2010 to 2025
| SEM Stock | USD 14.84 0.08 0.54% |
Noncontrolling Interest In Consolidated Entity | First Reported 2011-06-30 | Previous Quarter 248 M | Current Value 255.5 M | Quarterly Volatility 77.4 M |
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.7 M, Interest Expense of 151.7 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0261 or PTB Ratio of 1.47. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
Select | Noncontrolling Interest In Consolidated Entity | Build AI portfolio with Select Stock |
Latest Select Medical's Noncontrolling Interest In Consolidated Entity Growth Pattern
Below is the plot of the Noncontrolling Interest In Consolidated Entity of Select Medical Holdings over the last few years. It is Select Medical's Noncontrolling Interest In Consolidated Entity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
| Noncontrolling Interest In Consolidated Entity | 10 Years Trend |
|
Noncontrolling Interest In Consolidated Entity |
| Timeline |
Select Noncontrolling Interest In Consolidated Entity Regression Statistics
| Arithmetic Mean | 129,786,470 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 74.87 | |
| Mean Deviation | 85,053,028 | |
| Median | 113,198,000 | |
| Standard Deviation | 97,167,064 | |
| Sample Variance | 9441.4T | |
| Range | 283.3M | |
| R-Value | 0.96 | |
| Mean Square Error | 724.1T | |
| R-Squared | 0.93 | |
| Slope | 19,665,171 | |
| Total Sum of Squares | 141621.6T |
Select Noncontrolling Interest In Consolidated Entity History
About Select Medical Financial Statements
Select Medical investors utilize fundamental indicators, such as Noncontrolling Interest In Consolidated Entity, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Noncontrolling Interest In Consolidated Entity | 269.8 M | 283.3 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Select Medical Correlation against competitors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.375 | Earnings Share 0.62 | Revenue Per Share | Quarterly Revenue Growth 0.024 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.